304 Antagonistic antibodies targeting LAIR1 enhance T lymphocyte activation and promote inflammatory phenotypes in myeloid cells

• Tao Huang,
• An Song,
• Ryan Stafford,
• Maria Jose Costa,
• Jing-Tyan Ma,
• Krista McCutcheon,
• Heyu Chen,
• Kyu Hong,
• Ningyan Zhang,
• Zhiqiang An,
• Cheng Cheng Zhang,
• X Charlene Liao,
• Caroline Bonnans,
• Azita Tabrizi,
• Jingjing Xie,
• Hongyu Tian,
• Xun Gui

Affiliations

Tao Huang

Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China

An Song

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Ryan Stafford

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Maria Jose Costa

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Jing-Tyan Ma

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Krista McCutcheon

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Heyu Chen

3University of Texas Southwestern, Dallas, TX, USA

Kyu Hong

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Ningyan Zhang

2University of Texas Health Science Center, Houston, TX, USA

Zhiqiang An

2University of Texas Health Science Center, Houston, TX, USA

Cheng Cheng Zhang

3University of Texas Southwestern, Dallas, TX, USA

X Charlene Liao

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Caroline Bonnans

1Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA

Azita Tabrizi

1Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA

Jingjing Xie

2UT Southwestern Medical Center, Dallas, TX, USA

Hongyu Tian

1Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA

Xun Gui

3UT Health Science Center, Houston, TX, USA